These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34067027)

  • 1. Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity.
    Darakjian L; Deodhar M; Turgeon J; Michaud V
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes: hypothesis with implications for personalized medicine.
    Shah RR; Smith RL
    Drug Metab Dispos; 2015 Mar; 43(3):400-10. PubMed ID: 25519488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of CYP450 Activities in Patients With Type 2 Diabetes.
    Gravel S; Chiasson JL; Turgeon J; Grangeon A; Michaud V
    Clin Pharmacol Ther; 2019 Dec; 106(6):1280-1289. PubMed ID: 31099895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case-control pharmacokinetic study.
    Gravel S; Chiasson JL; Dallaire S; Turgeon J; Michaud V
    BMJ Open; 2018 Feb; 8(2):e020922. PubMed ID: 29439084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation.
    Kugler N; Klein K; Zanger UM
    Biochem Pharmacol; 2020 Jan; 171():113725. PubMed ID: 31758923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review.
    Klomp SD; Manson ML; Guchelaar HJ; Swen JJ
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32906709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome.
    Dos Santos LRB; Fleming I
    Prostaglandins Other Lipid Mediat; 2020 Jun; 148():106407. PubMed ID: 31899373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic cytochrome P450 regulation in disease states.
    Cheng PY; Morgan ET
    Curr Drug Metab; 2001 Jun; 2(2):165-83. PubMed ID: 11469724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Serum TNF-
    Alzamil H
    J Obes; 2020; 2020():5076858. PubMed ID: 32089876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Evaluation of
    Giorgetti A; Amurri S; Fazio G; Bini C; Anniballi L; Pirani F; Pelletti G; Pelotti S
    Metabolites; 2023 May; 13(5):. PubMed ID: 37233702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats.
    Nadai M; Sekido T; Matsuda I; Li W; Kitaichi K; Itoh A; Nabeshima T; Hasegawa T
    J Pharm Pharmacol; 1998 Aug; 50(8):871-9. PubMed ID: 9751451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HepaRG cells as human-relevant in vitro model to study the effects of inflammatory stimuli on cytochrome P450 isoenzymes.
    Rubin K; Janefeldt A; Andersson L; Berke Z; Grime K; Andersson TB
    Drug Metab Dispos; 2015 Jan; 43(1):119-25. PubMed ID: 25371393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pilot Study towards the Impact of Type 2 Diabetes on the Expression and Activities of Drug Metabolizing Enzymes and Transporters in Human Duodenum.
    Gravel S; Panzini B; Belanger F; Turgeon J; Michaud V
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting.
    Mostafa S; Polasek TM; Sheffield LJ; Huppert D; Kirkpatrick CMJ
    Front Psychiatry; 2021; 12():724170. PubMed ID: 34489765
    [No Abstract]   [Full Text] [Related]  

  • 15. Imbalanced low-grade inflammation and endothelial activation in patients with type 2 diabetes mellitus and erectile dysfunction.
    Araña Rosaínz Mde J; Ojeda MO; Acosta JR; Elías-Calles LC; González NO; Herrera OT; García Álvarez CT; Rodríguez EM; Báez ME; Seijas EÁ; Valdés RF
    J Sex Med; 2011 Jul; 8(7):2017-30. PubMed ID: 21554550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus.
    Karvonen I; Stengård JH; Huupponen R; Stenbäck FG; Sotaniemi EA
    Diabetes Res; 1989 Feb; 10(2):85-92. PubMed ID: 2501061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes.
    Barnett CR; Abbott RA; Bailey CJ; Flatt PR; Ioannides C
    Biochem Pharmacol; 1992 Apr; 43(8):1868-71. PubMed ID: 1575780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure.
    Frye RF; Schneider VM; Frye CS; Feldman AM
    J Card Fail; 2002 Oct; 8(5):315-9. PubMed ID: 12411982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors involved in phenoconversion of CYP3A using 4β-hydroxycholesterol in stable kidney transplant recipients.
    Suzuki Y; Muraya N; Fujioka T; Sato F; Tanaka R; Matsumoto K; Sato Y; Ohno K; Mimata H; Kishino S; Itoh H
    Pharmacol Rep; 2019 Apr; 71(2):276-281. PubMed ID: 30826567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.